Detroit, MI – December 1, 2025 – Functional Fluidics, a leader in red blood cell health innovation, will showcase new scientific insights at the upcoming American Society of Hematology (ASH) Annual Meeting and Exposition, held December 6–9, 2025, at the Orange County Convention Center in Orlando, Florida.
The ASH Annual Meeting is the premier global forum for groundbreaking research, clinical advancements, and emerging technologies in hematology, drawing thousands of clinicians, scientists, and industry experts from around the world.
At this year’s conference, Functional Fluidics will share new data through both a scientific workshop presentation and a poster session.
Functional Fluidics Scientific Workshop
Title: Endpoints and Surrogate Biomarkers
Part of Session: Scientific Workshop on Disease Severity Scoring and Clinical Trial Endpoints Beyond Vaso-occlusive Pain in Sickle Cell Disease
Date and Time: Friday, December 5, 03:45 PM - 04:35 PM
Location: W315, Orange County Convention Center
Presentation: Adhesions and Red Cell Health as a Marker of Propensity of VOC
Presenter: Patrick Hines, MD/PhD, Founder and CEO, Functional Fluidics
https://submit.hematology.org/program/session/117480
Functional Fluidics Oral Poster Session
Title: 1160- Assessment of red blood cell functional biomarkers following hematopoietic cell transplantation in sickle cell disease patients
Poster Abstract Session: 113. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I
Date & Time: Saturday, December 6, 2025, 5:30 PM - 7:30 PM
Location: West Halls B3-B4, Orange County Convention Center
Presenter: Patrick Hines, MD/PhD, Founder and CEO, Functional Fluidics
https://meetings-api.hematology.org/api/abstract/vmpreview/303175
“Functional Fluidics is proud to share new scientific advances at this year’s ASH Annual Meeting, the leading global forum for innovation in hematology,” said Patrick Hines, MD/PhD, Founder and CEO of Functional Fluidics. “Our latest data underscore the growing importance of red blood cell functional biomarkers as objective tools to support clinical decision-making, enhance patient monitoring, and ultimately improve outcomes for individuals living with sickle cell disease.”
About Functional Fluidics
Founded in 2014, Functional Fluidics is a global health technology company specializing in red blood cell health, that leverages healthcare data and technologies to accelerate the development of life-changing therapies, support clinical trials, and bridge the gap between clinical research and patient care. Functional Fluidics is also the innovator behind Red Blood Cell Functionomics™, a comprehensive framework that makes red blood cell health measurable and clinically actionable. The company has locations in North America and Sub-Saharan Africa and partners with healthcare providers, researchers, and pharmaceutical organizations globally.
For more information on our company, visit our website or follow us on our social media platforms.
Media Contact:
Nadine Russell, MBA
Global Business Director
Functional Fluidics, Inc.
info@functionalfluidics.com